Search Editorial Photos
"nvax"
10 professional editorial images found
#6666838
29 April 2021
Novavax logo is displayed on a mobile phone screen for illustration photo taken in Krakow, Poland on April 29, 2021. Novavax NVAX is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6666836
29 April 2021
Novavax logo is displayed on a mobile phone screen photographed on European Union flag background arranged for illustration photo taken in Krakow, Poland on April 29, 2021. Novavax NVAX is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6666834
29 April 2021
Novavax logo is displayed on a mobile phone screen photographed on U.S. national flag background arranged for illustration photo taken in Krakow, Poland on April 29, 2021. Novavax NVAX is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6666832
29 April 2021
Novavax logo is displayed on a mobile phone screen photographed on U.S. national flag background arranged for illustration photo taken in Krakow, Poland on April 29, 2021. Novavax NVAX is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6666830
29 April 2021
Novavax logo is displayed on a mobile phone screen photographed on European Union flag background arranged for illustration photo taken in Krakow, Poland on April 29, 2021. Novavax NVAX is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6666828
29 April 2021
Novavax logo is displayed on a mobile phone screen photographed on European Union flag background arranged for illustration photo taken in Krakow, Poland on April 29, 2021. Novavax NVAX is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6666824
29 April 2021
Novavax logo is displayed on a mobile phone screen for illustration photo taken in Krakow, Poland on April 29, 2021. Novavax NVAX is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6666822
29 April 2021
Novavax logo is displayed on a mobile phone screen photographed on U.S. national flag background arranged for illustration photo taken in Krakow, Poland on April 29, 2021. Novavax NVAX is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6666820
29 April 2021
Novavax logo is displayed on a mobile phone screen photographed on U.S. national flag background arranged for illustration photo taken in Krakow, Poland on April 29, 2021. Novavax NVAX is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6666818
29 April 2021
Novavax logo is displayed on a mobile phone screen photographed on U.S. national flag background arranged for illustration photo taken in Krakow, Poland on April 29, 2021. Novavax NVAX is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.